Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)
Tadashi Watabe(Osaka University), Kazunori Kato(Toyo University)
European Journal of Nuclear Medicine and Molecular Imaging
February 12, 2025
Cited by 6
Related Papers
Evaluation of Functional Connectivity in the Brain Using Positron Emission Tomography: A Mini-Review
|Frontiers in Neuroscience|2019|31
Serum EphA2 as a Promising Biomarker for the Early Detection and Diagnosis of Colorectal Cancer
|Biomolecules|2024|2
Ergothioneine Attenuates Oxaliplatin-Induced Peripheral Neuropathy Without Compromising Antitumor Efficacy
|International Journal of Molecular Sciences|2025|1